iCure, Stock Price 69,800 KRW (-7.92%)... Bulletin Board 'Bustling'
At this time, posts about iCure are rapidly increasing on portals and stock communities. Today, foreigners have tentatively purchased a net 4,000 shares of iCure, while institutions have sold a net 4,000 shares. iCure is known as a company possessing core technology for transdermal drug delivery systems.
As of 1:30 PM on the 17th, iCure's stock price is 69,800 KRW, down 7.92% from the previous day, with a trading volume of 757,713 shares, which is 60.49% of the 5-day average trading volume. On February 16, iCure became a market issue with the headline "Despite successful Phase 3 clinical trials of dementia patches with Celltrion, stock declines."
In addition to iCure, posts by investors are also rapidly increasing for Showbox (086980), Nivek (138610), and Interpark (035080).
Hot Picks Today
!["It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]](https://cwcontent.asiae.co.kr/asiaresize/93/2026052019230771274_1779272587.jpg)
"It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
- "Am I Really in the Top 30%?" and "Worried About My Girlfriend in the Bottom 70%"... Buzz Over High Oil Price Relief Fund
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
※Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
